Azevedo S, Lopes A
Children (Basel). 2025; 11(12.
PMID: 39767921
PMC: 11674067.
DOI: 10.3390/children11121492.
Petrik M, Kuhn T, Kinsinger S
J Clin Psychol Med Settings. 2024; 31(2):237-244.
PMID: 38734760
DOI: 10.1007/s10880-024-10006-8.
MKoma A
Gastrointest Disord (Basel). 2023; 1(1):75-105.
PMID: 37577036
PMC: 10416806.
DOI: 10.3390/gidisord1010007.
MKoma A, Ware J, Nabaweesi R, Chirwa S
Med Res Arch. 2023; 11(6).
PMID: 37492395
PMC: 10367541.
DOI: 10.18103/mra.v11i6.3784.
Pascoal C, Ferreira I, Teixeira C, Almeida E, Slade A, Brasil S
Orphanet J Rare Dis. 2022; 17(1):398.
PMID: 36309700
PMC: 9618201.
DOI: 10.1186/s13023-022-02551-y.
Trends in inflammatory bowel disease infections and vaccinations in the past four decades: A high-level text mining analysis of PubMed publications.
Klang E, Soffer S, Shachar E, Lahat A
Hum Vaccin Immunother. 2022; 18(5):2065814.
PMID: 35471850
PMC: 9897639.
DOI: 10.1080/21645515.2022.2065814.
Capsule Endoscopy in Crohn's Disease-From a Relative Contraindication to Habitual Monitoring Tool.
Lahat A, Veisman I
Diagnostics (Basel). 2021; 11(10).
PMID: 34679435
PMC: 8534609.
DOI: 10.3390/diagnostics11101737.
Trends in inflammatory bowel disease treatment in the past two decades-a high-level text mining analysis of PubMed publications.
Klang E, Barash Y, Soffer S, Shachar E, Lahat A
United European Gastroenterol J. 2021; 9(9):1019-1026.
PMID: 34431607
PMC: 8598961.
DOI: 10.1002/ueg2.12138.
Work and School Absenteeism in Inflammatory Bowel Disease Patients in Jeddah, Saudi Arabia: A Cross-Sectional Study.
Mosli M, Alamri A, Saadah O
Saudi J Med Med Sci. 2021; 9(2):159-166.
PMID: 34084107
PMC: 8152386.
DOI: 10.4103/sjmms.sjmms_79_20.
Substance P failed to reverse dextran sulfate sodium-induced murine colitis mediated by mitochondrial dysfunction: implications in ulcerative colitis.
Chandraiah S, Ghosh S, Saha I, More S, Annappa G, Maiti A
3 Biotech. 2021; 11(4):199.
PMID: 33927989
PMC: 8006204.
DOI: 10.1007/s13205-021-02755-2.
Ulcerative colitis.
Kobayashi T, Siegmund B, Le Berre C, Wei S, Ferrante M, Shen B
Nat Rev Dis Primers. 2020; 6(1):74.
PMID: 32913180
DOI: 10.1038/s41572-020-0205-x.
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.
Facchin S, Vitulo N, Calgaro M, Buda A, Romualdi C, Pohl D
Neurogastroenterol Motil. 2020; 32(10):e13914.
PMID: 32476236
PMC: 7583468.
DOI: 10.1111/nmo.13914.
Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study.
Le Berre C, Bourreille A, Flamant M, Bouguen G, Siproudhis L, Dewitte M
BMC Gastroenterol. 2020; 20(1):110.
PMID: 32299390
PMC: 7164208.
DOI: 10.1186/s12876-020-01246-7.
Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?.
van Andel E, Koopmann B, Crouwel F, Noomen C, de Boer N, van Asseldonk D
J Crohns Colitis. 2020; 14(9):1299-1315.
PMID: 32211749
PMC: 7493218.
DOI: 10.1093/ecco-jcc/jjaa057.
Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors - A cross-sectional study.
Marinelli C, Savarino E, Marsilio I, Lorenzon G, Gavaruzzi T, DInca R
Sci Rep. 2020; 10(1):507.
PMID: 31949257
PMC: 6965196.
DOI: 10.1038/s41598-020-57460-6.
Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients.
Marinelli C, Savarino E, Inferrera M, Lorenzon G, Rigo A, Ghisa M
Gastroenterol Res Pract. 2019; 2019:5354320.
PMID: 31531015
PMC: 6721452.
DOI: 10.1155/2019/5354320.
Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease.
Chao C, Lemieux C, Restellini S, Afif W, Bitton A, Lakatos P
Saudi J Gastroenterol. 2019; 25(3):159-166.
PMID: 30900609
PMC: 6526742.
DOI: 10.4103/sjg.SJG_566_18.
Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension study.
Panes J, DHaens G, Higgins P, Mele L, Moscariello M, Chan G
Aliment Pharmacol Ther. 2019; 49(3):265-276.
PMID: 30663107
PMC: 6646954.
DOI: 10.1111/apt.15072.
Health-related quality of life of patients with inflammatory bowel disease in Singapore.
Min Ho P, Hu W, Lee Y, Gao C, Tan Y, Cheen H
Intest Res. 2018; 17(1):107-118.
PMID: 30419638
PMC: 6361019.
DOI: 10.5217/ir.2018.00099.
Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties.
Chen X, Zhong L, Wen Y, Liu T, Li X, Hou Z
Health Qual Life Outcomes. 2017; 15(1):177.
PMID: 28915891
PMC: 5603012.
DOI: 10.1186/s12955-017-0753-2.